
| 4 min read
A failed RNA drug, major job cuts, a win for myeloma CAR T, and more led the news this week.
| 3 min read
Starting from a defined mechanism can cause discovery programs to miss the best drug candidates.
| 3 min read
Researchers at Erasmus MC and Apeximmune independently identified PLA2G2D as a potential new target for restoring antitumor T cell responses.
| 7 min read
This year’s awardees were recognized for their achievements in the discovery of orexin, the development of a novel bispecific antibody, and bringing patients to the forefront of drug discovery.News
Cancer Research News
Transgene expands a duck-cell-line license as its personalized cancer vaccines advance deeper into the clinic
A newly certified DPYD genotyping assay gives oncologists a validated way to flag chemotherapy toxicity risk before treatment starts
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Repetitive pipetting can strain the hands, wrists, shoulders, and neck, making ergonomics an important part of efficient liquid handling.
Explore how high-dimensional flow cytometry can expand immune profiling and support immunotoxicology assessment during preclinical drug development.




















